CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$3.61
-0.11 (-2.96%)
As of Nov 7, 10:02 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +727.7% upside
Low Target $20.40
Average Target $29.88
High Target $34.19
Current Price $3.61
Current
$3.61
Target
$29.88
$20.40 $29.88 avg $34.19
Scenario Analysis
Bear Case
$20.40
465.1%
Low target
Base Case
$29.88
+727.7%
Avg target
Bull Case
$34.19
+847.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.47
-34.0% from high
52-Week Low
$3.23
+11.8% from low
Target vs 52W High
$29.88
+446.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%